moxifloxacin has been researched along with Acute Kidney Failure in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guggemos, W; Seilmaier, M | 1 |
Amann, K; Bröcker, EB; Müller, PA; Trautmann, A | 1 |
Ahmed, S; Fuhrmann, V; Jaeger, W; Schenk, P; Thalhammer, F | 1 |
Czock, D; de Groot, K; Fliser, D; Hafer, C; Haller, H; Hüsig-Linde, C; Keller, F; Kielstein, JT; Kuse, E; Langhoff, A; Schöpke, T; Swoboda, S | 1 |
4 other study(ies) available for moxifloxacin and Acute Kidney Failure
Article | Year |
---|---|
[Severe febrile illness with renal impairment after travel to Southeast Asia].
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Asia, Southeastern; Aza Compounds; Ceftriaxone; Fever of Unknown Origin; Fluoroquinolones; Humans; Leptospirosis; Male; Moxifloxacin; Quinolines; Travel; Treatment Outcome | 2008 |
[Maculo-papular exanthem with acute renal failure. Drug-induced hypersensitivity syndrome].
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Aortic Valve; Aza Compounds; Biopsy; Diagnosis, Differential; Drug Eruptions; Drug Therapy, Combination; Endocarditis, Bacterial; Eosinophilia; Fluoroquinolones; Glucocorticoids; Humans; Kidney; Legionnaires' Disease; Male; Meropenem; Moxifloxacin; Nephritis, Interstitial; Quinolines; Sepsis; Skin; Thienamycins; Vancomycin | 2012 |
Pharmacokinetics of moxifloxacin in patients undergoing continuous venovenous haemodiafiltration.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; Chromatography, High Pressure Liquid; Drug Administration Schedule; Female; Fluoroquinolones; Hemodiafiltration; Hemodialysis Solutions; Humans; Injections, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Moxifloxacin; Quinolines; Severity of Illness Index | 2004 |
Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Anuria; Aza Compounds; Critical Care; Critical Illness; Female; Fluoroquinolones; Humans; Intensive Care Units; Levofloxacin; Male; Metabolic Clearance Rate; Middle Aged; Moxifloxacin; Multiple Organ Failure; Ofloxacin; Quinolines; Renal Dialysis; Sepsis | 2006 |